Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Sep 9, 2024; 13(3): 93697
Published online Sep 9, 2024. doi: 10.5409/wjcp.v13.i3.93697
Role of iron deficiency anemia in inflammatory bowel disease
Seema Rai
Seema Rai, Department of Pediatrics, Guru Gobind Singh Medical College & Hospital, Faridkot 151203, Punjab, India
Author contributions: Rai S conceptualized, drafted, and revised the manuscript.
Conflict-of-interest statement: The author has no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed by the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Seema Rai, MD, Adjunct Associate Professor, Associate Professor, Department of Pediatrics, Guru Gobind Singh Medical College & Hospital, Sadiq Road, Faridkot 151203, Punjab, India. seemadoc98@yahoo.co.uk
Received: March 4, 2024
Revised: May 28, 2024
Accepted: July 10, 2024
Published online: September 9, 2024
Processing time: 179 Days and 3.6 Hours
Core Tip

Core Tip: Iron deficiency is related to many complications in patients with inflammatory bowel disease (IBD) and further increases the mortality and morbidity in this patient group. The effective management of iron deficiency (ID) is essential to improve these patients' lifestyles and health-related complications. ID correlates with the disease activity in IBD and the tendency to relapse even after successful ID therapy. Parenteral iron therapy, a promising avenue, is showing potential in improving the target hemoglobin level in IBD patients.